Lista de obras - Eli Muchtar - Dominio Público Uruguay

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A practical review on carfilzomib in multiple myeloma

artículo científico publicado en 2016

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

artículo científico publicado en 2020

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation

scientific article published on 13 June 2017

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

artículo científico publicado en 2018

Antiviral prophylaxis in haematological patients: systematic review and meta-analysis

artículo científico publicado en 2009

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

artículo científico publicado en 2018

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

artículo científico publicado en 2018

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

artículo científico publicado en 2020

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

artículo científico publicado en 2020

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bone mineral density utilization in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2016

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

artículo científico publicado en 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

artículo científico publicado en 2020

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

artículo científico publicado en 2019

Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement

artículo científico publicado en 2020

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

artículo científico publicado en 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

artículo científico publicado en 2020

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer

artículo científico publicado en 2017

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

artículo científico publicado en 2020

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

artículo científico publicado en 2017

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

artículo científico publicado en 2017

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

artículo científico publicado en 2020

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

First line and salvage therapy with total therapy 3-based treatment for multiple myeloma- an extended single center experience.

artículo científico publicado en 2014

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

artículo científico publicado en 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease

scientific article published on 01 May 2020

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

How I treat cryoglobulinemia.

artículo científico publicado en 2016

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

artículo científico publicado en 2016

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

artículo científico publicado en 2016

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

artículo científico publicado en 2017

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

artículo científico publicado en 2018

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

artículo científico publicado en 2020

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2016

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

artículo científico publicado en 2020

Importance of FISH genetics in light chain amyloidosis

artículo científico publicado en 2017

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

artículo científico publicado en 2017

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

scientific article published on 25 May 2020

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

artículo científico publicado en 2018

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

artículo científico publicado en 2020

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

artículo científico publicado en 2019

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

New developments in diagnosis, risk assessment and management in systemic amyloidosis

scientific article published on 02 November 2019

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

artículo científico publicado en 2019

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

artículo científico publicado en 2017

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

artículo científico publicado en 2018

Predictors of short-term survival in Waldenström Macroglobulinemia

artículo científico publicado en 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

artículo científico publicado en 2019

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

artículo científico publicado en 2020

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

artículo científico publicado en 2019

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

artículo científico publicado en 2020

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.

artículo científico publicado en 2017

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

artículo científico publicado en 2018

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

artículo científico publicado en 2017

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

artículo científico publicado en 2018

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

artículo científico publicado en 2010

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

artículo científico publicado en 2016

Systemic amyloidosis from A (AA) to T (ATTR): a review

scientific article published on 14 September 2020

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

Testicular plasmacytoma: unique location or circumstantial presentation?

artículo científico publicado en 2018

The colorful landscape of multiple myeloma

scientific article published on 27 February 2019

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2019

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

artículo científico publicado en 2016

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

Uninvolved immunoglobulins predicting hematological response in newly diagnosed AL amyloidosis.

artículo científico publicado en 2015

Unravelling hypothyroidism in AL amyloidosis: Authors' reply.

artículo científico publicado en 2017

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

artículo científico publicado en 2020

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2018

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

artículo científico publicado en 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

artículo científico publicado en 2019

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

artículo científico publicado en 2020

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Lista de obras de Eli Muchtar

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

A practical review on carfilzomib in multiple myeloma

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

Antiviral prophylaxis in haematological patients: systematic review and meta-analysis

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Bone mineral density utilization in patients with newly diagnosed multiple myeloma

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

Characterization and prognostic implication of delayed complete response in AL amyloidosis

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

Comparative analysis of staging systems in AL amyloidosis

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

First line and salvage therapy with total therapy 3-based treatment for multiple myeloma- an extended single center experience.

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Glycosylation of Immunoglobulin Light Chains is Highly Prevalent in Cold Agglutinin Disease

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

How I treat cryoglobulinemia.

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

Importance of FISH genetics in light chain amyloidosis

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

New developments in diagnosis, risk assessment and management in systemic amyloidosis

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

Predictors of short-term survival in Waldenström Macroglobulinemia

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

Revisiting complete response in light chain amyloidosis

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.